XML 88 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONCENTRATIONS
 12 Months Ended
Dec. 31, 2012
Risks and Uncertainties [Abstract]  
Concentration Risk Disclosure [Text Block]
18. CONCENTRATIONS

 

Major Customers

 

For the years ended December 31, 2012 and 2011, approximately 13% of the Company’s revenues were received from each of two customers.

 

At December 31, 2011, receivables from two customers were approximately 12% and 10%, respectively. No customer represented more than 10% of amounts receivable at December 31, 2012.

 

Major Suppliers

 

At December 31, 2012 and 2011, payables due to three suppliers were approximately 34%, 33%, 19% and 50%, 8%, 6%, respectively.

 

Revenues

 

For the years ended December 31, 2012 and 2011, the Company’s top three selling products accounted, in the aggregate, for approximately 68% and 27%, respectively, of its total net revenues.

 

The following represents the revenues by product line, all derived from China:

 

    For the years ended
December 31,		  
    2012     2011  
  US$     US$  
Products Line            
             
Medical Devices     18,547,635       19,362,673  
Respiratory and Oxygen Homecare     2,822,690       2,276,610  
      21,370,325       21,639,283